Garcia Campelo MR, Wan Y, Lin HM, Chen T, et al. Q-TWiST analysis of survival benefits with brigatinib versus crizotinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer based on results of the ALTA-1L trial. Lung Cancer 2023;185:107376.
PMID: 37722340